AflacAFL
Recorded

Aflac 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration51 minParticipants14

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good day, and welcome to the Aflac Incorporated Third Quarter 2026 Earnings Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note, this event is being recorded. I would now like to hand the call to David Young, Senior Vice President, Capital Markets. Please go ahead. Good morning, and welcome.

David YoungSVP of Capital Markets

Thank you for joining us for Aflac Incorporated's Third Quarter 2026 Earnings Call. This morning, Dan Amos, Chairman, CEO of Aflac Incorporated, will provide an overview of our results and operations in Japan and the U.S. Then Max Brodén, Senior Executive Vice President and CFO of Aflac Incorporated, will provide more detail on our third quarter financial results, including our capital and liquidity. These topics are also addressed in the materials we posted with our earnings release, financial supplement, and quarterly CFO video update on investors.aflac.com.

David YoungSVP of Capital Markets

For Q&A today, we are also joined by Virgil Miller, President of Aflac Incorporated and Aflac U.S.; Fred Simard, Deputy President of Aflac U.S.; Charles Lake, Chairman and Representative Director, President of Aflac International; Masatoshi Koide, President and Representative Director, Aflac Life Insurance Japan; Shinsuke Morimoto, Deputy President, Aflac Life Insurance Japan; Brad Dyslin, Global Chief Investment Officer, President of Aflac Global Investments. Before we begin, some statements in this teleconference are forward-looking within the meaning of federal securities laws. Although we believe these statements are reasonable, we can give no assurance that they will prove to be accurate because they are prospective in nature. Actual results could differ materially from those we discuss today. We encourage you to look at our annual report on Form 10-K for some of the various risk factors that could materially impact our results.

David YoungSVP of Capital Markets

As I mentioned earlier, the earnings release with reconciliations of certain non-U.S. GAAP measures and related earnings materials are available on investors.aflac.com. I'll now hand the call over to Dan.

Dan AmosChairman and CEO

Dan? Thank you, David, and good morning, everyone.

Dan AmosChairman and CEO

We're glad you've joined us. You probably saw our announcement earlier this week about leadership promotions for Aflac Japan and Aflac U.S. that will be effective January 1, 2027. Deputy President of Aflac Japan, Shinsuke Morimoto, will be promoted to President of Aflac Japan and Representative Director. Also, Deputy President of Aflac U.S., Fred Simard, will be promoted to President of Aflac U.S. Masatoshi Koide, currently President of Aflac Japan, Representative Director, will assume the role of Chairman of Aflac Japan and Representative Director. Charles Lake will become Executive Advisor of Aflac Japan and assume the role of Chairman of Aflac International. These leadership announcements are the results of long-term and deliberate succession planning process and coordination overseen by Aflac Incorporated's board of directors to ensure we have the right people in the right places at the right time.

Dan AmosChairman and CEO

Virgil and I agree that the strength of the leadership bench is a testament to the strong foundation created by Charles and Koide-san, whose leadership has had a tremendous positive impact on Aflac Japan and across the Aflac organization. We are excited as each esteemed leader takes on new challenges and opportunities. Now, turning to the results, Aflac Incorporated reported third quarter net earnings per diluted share of $0.61 and adjusted earnings per diluted share of $2.43, as we executed on our strategy of creating long-term value for our shareholders. Starting with Aflac Japan, as we communicated last quarter, we were against a challenging third quarter of 2025 sales comparison following the launch of Miraito Cancer Insurance. As a result, sales declined 4% to JPY 18.8 billion in the quarter, but we were up 3% for the first nine months of the year.

Dan AmosChairman and CEO

Sales of Tsumitasu were up both year-over-year and sequentially. Sales of Anshin Palette, our medical insurance product launched in December of 2025, increased over the prior year. Despite the tough sales comparisons, Miraito faces sales of this cancer insurance product remain relatively strong as Japanese citizens recognize the need to partner with well-respected brand for financial protection against cancer. We continue to expect Aflac Japan sales to exceed 2025. For the quarter, premium persistency was 92.9%, which was solid and in line with our expectations. By maintaining strong persistency while adding new premium through sales, we seek to offset the impact of lapses and reissue, as well as policies reaching paid-up status. Our extensive network of distribution channels, including agencies, alliance partners, and banks, continually look for opportunities to help provide financial protection to Japanese consumers.

Dan AmosChairman and CEO

We regard each channel as a distinct avenue to approach Japanese consumers in different demographics and stages of life. With this approach in mind, we evaluate and support each sales channel uniquely. Turning to Aflac U.S., we remain well-positioned to serve employers and employees with supplemental health products and related benefits and solutions. We are committed to our ongoing pursuit of profitable growth while maintaining strong underwriting discipline and premium persistency. Aflac U.S. generated a year-over-year 3.5% increase in sales for the third quarter. We are seeing momentum within our group business, especially group life, absence and disability, and network dental offerings. We generated a 3.3% increase in net earned premium for the quarter and maintained strong premium persistency of 79.7%. At the same time, Aflac U.S. has maintained a solid pre-tax profit margin of 27.7%.

Dan AmosChairman and CEO

As a public insurance company, our primary responsibility is to fulfill the promises we make to our policyholders while being responsive to the needs of our shareholders. We continue to be pleased with our investments producing solid investment income. Our operations generate strong capital and cash flows on an ongoing basis as we remain committed to prudent liquidity and capital management. This financial strength is the foundation that backs up our promise to our policyholders, balanced with financial flexibility and tactical capital deployment. We treasure our 2026 milestone of 44 consecutive years of dividend increases. Combining share repurchase and dividend, we delivered $1.1 billion back to the shareholders in the third quarter and $3.7 billion for the first nine months. In doing so, we have maintained our position among companies with the highest return on capital and one of the lowest cost of capital in the industry.

Dan AmosChairman and CEO

We continue to pursue more profitable growth and make tactical opportunistic deployment of capital while being there for our policyholders when they need us most. The Japanese and U.S. insurance markets remain among the most dynamic and resilient insurance markets in the world. In both countries, rising healthcare costs continue to place pressure on household budgets, increasing the need for supplemental insurance solutions when unexpected medical expenses occur. What differentiates us at Aflac is not only the experience and expertise our company has gathered in the seven decades of operation, but also our purpose. As a pioneer in cancer insurance and a recognized industry leader, our employees, sales team work every day to deliver solutions that help protect financial well-being while reflecting the compassion, empathy, and trust that are known as hallmarks of our brand.

Dan AmosChairman and CEO

The ongoing foundational strengths of our business and our capacity for continued growth support our leading position and build on the momentum. Now I'd like to turn the program over to Max.

Max BrodénSenior EVP and CFO

Max? Thank you, Dan. For the third quarter of 2026, adjusted earnings per diluted share decreased 1.2% year-over-year to $2.46, excluding the effect of foreign currency in the quarter.

Max BrodénSenior EVP and CFO

In this quarter, remeasurement gains on reserves from the actuarial assumption unlock, including deferred profit liability, totaled $447 million on a pre-tax basis. Remeasurement gains also included $55 million of experience remeasurement on reserves, which was $2 million below plan, with no impact on earnings per share. The total net impact from the Q3 assumption update increased earnings per share by $0.71. In addition, third quarter results included $40 million, or $0.06 per diluted share, of cybersecurity expenses and enhancements in Japan. Variable investment income ran $22 million, or $0.03 per diluted share, below our long-term return expectations.

Max BrodénSenior EVP and CFO

Adjusted book value per share, excluding foreign currency remeasurement, decreased 6.4%. The adjusted ROE was 17.8% and 23.7% excluding foreign currency remeasurement, a very significant spread to our cost of capital. Overall, we view these results in the quarter as solid. Starting with our Japan segment, net earned premiums in yen terms for the quarter declined 2%. Aflac Japan's underlying earned premiums, which excludes the impact of reinsurance, paid-up policies, and deferred profit liability, declined 1.2%, roughly in line with where we expect to be for the full year. Japan's total benefit ratio came in at 49.2% for the quarter, up 990 basis points year-over-year, reflecting a larger actuarial assumption unlock in the prior year. We estimate that the impact from reserve remeasurement gains, excluding the unlock, was under plan by approximately 40 basis points in Q3 2026.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day